Company intelligence / Profile preview

BioLASCO

Ownership: Private
Employees: ~91
Development stage: Commercial

Overview

BioLASCO is the leading supplier of Specific Pathogen Free (SPF) laboratory mice and rats in Taiwan, providing high-quality animal models, breeding services, equipment for animal facilities, and related testing platforms to support life science research and pharmaceutical development. The company collaborates with global leaders such as Charles River Laboratories and The Jackson Laboratory to import specialized disease model animals. It operates AAALAC-accredited breeding centers in Asia and has expanded its operations into India and Thailand.

Industry: Drug Discovery Services

Partnerships

Charles River Laboratories (CRL)The Jackson LaboratoryMarshall Farms

Beyond the preview

Go deeper on BioLASCO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioLASCO.

Explore the full profile